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ABSTRACT
Aminoalkylated chalcone compounds (4a-4c) have been designed using Quantitative Structure-Activity Relationship 
(QSAR) analysis, synthesized and evaluated for their in vitro antimalarial activity. The best QSAR model obtained was 
log IC50 = 705.132 (qC7) - 65.573 (qC3) - 24.845 (qC4) - 4.634 (qC13) - 220.479 and statistical analysis showed R
2 
of 0.937, suggesting that the QSAR model was able to predict the actual antimalarial activity by 93.7% accuracy. The 
addition of secondary amines to the chalcone compounds was successfully carried out using the Mannich reaction, 
which was confirmed by spectroscopic analysis. The in vitro antimalarial activity of the synthesized compounds were 
screened against the 3D7 strain of Plasmodium falciparum (CQ sensitive). All of the compounds exhibited strong activ-
ity with IC50 values ranging from 0.54 ± 0.649 to 1.12 ± 0.369 µM. The molecular docking studies investigated interac-
tions of the prepared compounds to the binding site of wild-type Plasmodium falciparum dihydrofolate reductase-
thymidylate synthase (Pf-DHFR-TS) (PDB ID: IJ3I) and quadruple mutant Pf-DHFR-TS (PDB ID: IJ3K). Some hydrogen 
bond and π – π interactions were observed with the side chain of Ala16, Asp54, Cys15, Leu164, Tyr170, and Met55 in 
both the wild and mutant Pf-DHFR types. It has also been found that all the tested compounds were obeyed the Lipin-
ski’s rule. This study proposed that compound 4b can be developed as the new lead of the antimalarial agent.
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ABSTRAK
Sebatian aminoteralkil kalkon (4a-4c) telah direka bentuk menggunakan analisis Hubungan Struktur-Aktiviti 
Kuantitatif (QSAR) telah disintesis dan dinilai untuk aktiviti antimalaria secara in vitro. Model QSAR terbaik yang 
diperoleh adalah log IC50 = 705.132 (qC7)-65.573 (qC3)-24.845 (qC4)-4.634 (qC13)-220.479 dan analisis statistik 
menunjukkan R2 sebanyak 0.937, seterusnya mencadangkan bahawa model QSAR ini berupaya untuk meramalkan 
aktiviti antimalaria sebenar dengan ketepatan 93.7%. Penambahan amina sekunder telah dijalankan menggunakan 
tindak balas Mannich dan disahkan melalui analisis spektroskopi. Kesemua sebatian disaring menentang strain 
Klorokuina-sensitif (3D7) Plasmodium falciparum. Semua sebatian menunjukkan aktiviti baik dengan nilai IC50 
antara 0.54 ± 0.649 sehingga 1.12 ± 0.369 μM. Interaksi sebatian ini juga dikaji melalui kajian dok pada tapak 
pengikatan protein jenis liar Pf-DHFR-TS (PDB ID: IJ3I) dan mutan Pf-DHFR-TS (PDB ID: IJ3K). Ikatan hidrogen 
dan interaksi π-π sebatian dengan rantai sisi asid amino Ala16, Asp54, Cys15, Leu164, Tyr170 dan Met55 jelas 
diperhatikan pada kedua-dua protein tersebut. Sebatian yang dikaji ini juga didapati mematuhi peraturan Lipinski. 
Potensi aktiviti antimalaria yang ditunjukkan oleh sebatian 4b mampu dibangunkan sebagai sebatian utama. 
Kata kunci: Antimalaria; kajian dok; kalkon; QSAR; tindak balas Mannich
INTRODUCTION
Malaria has become the target of eradication in 2050, as 
mentioned in the Global Malaria Programme (GMP) by 
WHO. In 2018, malaria cases were reported up to 228 
million cases worldwide, with 405 thousand mortalities 
(WHO 2018). The resistance of the Plasmodium parasite 
to the antimalarial drugs, such as chloroquine (CQ) and 
artemisinin, is pointed out as the main factor that leads to 
the high mortality cases (Ashley et al. 2014; Sibley 2015). 
Some efforts have been made to decrease the fatality rate 
by exploring traditional therapies (Chen et al. 1994), 
developing combination drugs (Bhasin & Nair 2003), 
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and also introducing the malaria vaccine (WHO 2019). 
However, these attempts do not show any significant 
result. For that reason, preventing the resistance of the 
Plasmodium parasite is needed to actualize the zero 
cases in 2050 by discovering new antimalarial drugs 
that are more effective and efficient than chloroquine or 
artemisinin. 
Chalcone is one of the natural compounds that has 
been reported to have many bioactivities such as anticancer 
(Elkhalifa et al. 2020; Yang et al. 2019; Zhang et al. 
2019), anti-inflammatory (Ur-Rashid et al. 2019; Wang 
et al. 2019a), antibacterial (Dan & Dai 2020; Khan et 
al. 2019), antioxidants (Wang et al. 2019b), antidiabetic 
(Rammohana et al. 2020; Shin et al. 2018), antivascular 
(Tuncel et al. 2013), antigiardial (Cáceres-Castillo et al. 
2020), antileukemia (Quaglio et al. 2019), and antimalarial 
(Jyoti et al. 2019; Reeta et al. 2019; Wilhelm et al. 2015). 
It has been reported that chalcone compounds with some 
functional groups such as prenyl and allyl (Syahri et al. 
2017b), hydroxyl and methoxy (Syahri et al. 2017a) were 
active as an antimalarial agent. However, their activity 
was relatively weak compared with chloroquine as the 
commercial drug. 
Chloroquine and quinine are known as antimalarial 
drugs bearing amines group. It has been suggested that an 
amine functional group plays a vital role in the antimalarial 
activity. According to Suwito et al. (2014) amine groups 
could form electrostatic interactions with amino acids 
from the protein of Plasmodium. The presence of the 
electrostatic interaction could disrupt the synthesis of 
protein so that the Plasmodium parasite could die. Thus, 
the substitution of secondary amine to the aromatic ring of 
chalcone is expected could give better antimalarial activity.
A theoretical study approach using Quantitative 
Structure-Activity Relationship (QSAR) analysis and 
molecular docking can predict the best biological activities 
of compounds. Currently, the theoretical approach by 
computational chemistry is paramount in the development 
of new drugs. This method can build a correlation 
between chemical structures and biological activities in a 
mathematical model, which can be statistically validated 
so that it can predict the bioactivities of a compound very 
well (Golbraikh 2003). 
In  th is  work,  we repor ted  the  des ign of 
aminoalkylated chalcone using QSAR analysis to 
recommend some compounds with better antimalarial 
activity. Furthermore, the proposed compounds were 
then synthesized through the Mannich reaction method 
to add amine groups, such as morpholine, piperidine, and 
diethylamine. Evaluation of their in vitro antimalarial 
activity was carried out against CQ-sensitive strain 
(3D7) of P. falciparum to confirm the QSAR analysis 
result. Molecular docking was performed to predict the 
interaction of the prepared compounds to the protein 
of CQ-sensitive dihydrofolate reductases-thymidylate 
synthase (PfDHFR-TS) (PDB ID: 1J3I) and CQ-resistance 
PfDHFR-TS (PDB ID: 1J3K).
MATERIALS AND METHODS
Chemicals used in the synthesis of chalcone compounds 
were 4-chloroacetophenone, vanillin (4-hydroxy-3-
methoxy benzaldehyde), sodium hydroxide, ethanol, 
hydrochloric acid, formaldehyde, morpholine, piperidine, 
diethylamine, hexane, ethyl acetate, and silica gel 
(60 GF254) for column chromatography and thin-layer 
chromatography (TLC). All chemicals for the synthesis 
were purchased from Aldrich, Acros, and Merck, and 
used without further purification otherwise stated. All 
the solvents used in the synthesis were in analysis and 
synthesis grade. The melting point of the synthesized 
compounds was determined using Electrothermal 9100 
at 10 °C/min temperature gradient (uncorrected). Mass 
spectra (MS) were recorded on Shimadzu-QP 2010S, 
and the proton (1H)‒ and carbon (13C)‒NMR spectra 
were recorded on a JEOL 500 MHz spectrometer with 
tetramethylsilane (TMS) as the internal standard.
COMPUTATIONAL WORK
The computational work was performed in a PC with 
a processor of Intel® Core™ i7 CPU M 350 4.54 GHz; 
RAM 8.00 GB. Gaussian 09 software was used to execute 
the quantum mechanical calculations. The multiple 
linear regression analysis using SPSS statistics 23.0 was 
employed to evaluate the obtained correlation models. 
Meanwhile, molecular docking was carried out using 
Discovery Studio 2016 (Accelrys, San Diego, USA). 
QSAR ANALYSIS
The data set used in the QSAR analysis was 25 (twenty-
five) aminoalkylated chalcone derivatives from the 
previously reported work (Wilhelm et al. 2015). Only 
aminoalkylated chalcone compounds that were reported 
to be active as antimalarial to D10 strains were used 
as a data set. From this data set, the nineteen compounds 
were used as the training set (internal evaluation) and six 
of them as the test set (external evaluation) (Table 2). The 
data set was divided by considering the antimalarial 
activity (IC50) of the test set compounds were in the range 
of the maximum and minimum of IC50 value of the training 
set (Jain et al. 2012). The in vitro antimalarial activity 
was expressed as the Inhibition Concentration values 
[IC50 (µg/mL)] and then converted to the logarithmic scale 
pIC50 [pIC50 = log IC50] and used as dependent variables 
in QSAR analysis. 
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Geometry optimization of the tested compounds 
was performed with the semi-empirical AM1 method 
in the Gaussian 09 software. A correlation analysis 
was performed in SPSS 23.0 software by taking each 
electronic descriptor as an independent variable and 
pIC50 as a dependent variable to select the predominant 
descriptors that affecting the antimalarial activity (Syahri 
et al. 2016). The regression coefficients values were 
estimated by applying the least square curve fitting 
method. The best QSAR model was chosen based on 
some statistical parameters, i.e., correlation coefficients 
(r2), standard estimation of error (SEE), F-ratio between 
the prediction (Fcalc) and observation (Ftable) activity (Fcalc/
Ftab), and predictive residual sum of square (PRESS) value 
(Frimayanti et al. 2011; Modak et al. 2013; Motta et al. 
2011).
GENERAL PROCEDURE FOR THE SYNTHESIS OF 
AMINOALKYLATED CHALCONE (4A-4C)
Chalcone derivatives 3 was synthesized through the 





















SCHEME 1. Reagents and conditions of synthesis: (i) sodium hydroxide (40%), ethanol, stir at room temperature 
overnight; (ii) secondary amine (R = morpholine, piperidine, diethylamine), formaldehyde, ethanol, stir overnight
mixture of 4-chloroacetophenone (1 mol) and vanillin 
(1 mol) was dissolved in ethanol (75 mL), and sodium 
hydroxide (40%) was then slowly added while stirring. 
The reaction was continued at room temperature overnight, 
and it was stopped when all the starting material has 
been consumed (monitored using TLC). The reaction 
mixture was then acidified using HCl solution (2 M), and 
the precipitate obtained was filtered and washed using 
distilled water. Purification of the product was carried 
out using silica gel column chromatography with hexane: 
ethyl acetate as an eluent mixture (10-50% gradient of 
ethyl acetate).
Synthesis of aminoalkylated chalcone 4a-4c was 
carried out using the Mannich reaction method. The 
mixture of chalcone 3 (30 mmol), formaldehyde (30 
mmol), and respective secondary amines (30 mmol) was 
added in 75 mL of ethanol (Scheme 1) and refluxed for 
24 h. After the reaction was completed (monitored using 
TLC), the solvent was evaporated under reduced pressure, 
and the precipitate obtained was purified using silica gel 
column chromatography with a mixture of hexane: ethyl 




Yellow crystals, yield 80%, m.p. 151-152 °C; GC-MS 
(C21H22ClNO4); [M]
+ 387. 1H -NMR (500 MHz, acetone-d6) 
δ (ppm): 2.56 (t, 4H); 3.70 (t, 4H); 3.77 (s, 2H); 3.89 (s, 
3H); 7.20 (s, 1H); 7.43 (s, 1H); 7.56 (J = 8.5 Hz, 1H); 7.71 
(d, J = 15.5 Hz, 1H); 7.74 (d, J = 15.5 Hz, 1H); 8.12 (d, J 
= 8.5 Hz, 2H);. 13C-NMR (125 MHz, acetone-d6) δ (ppm): 
52.99. 56.19; 61.51; 66.85; 110.54; 118.91; 121.05; 122.97; 





Yellow crystals, yield 75%, m.p. 150-151 °C; GC-MS 
(C22H24ClNO3); [M]
+ 385. 1H-NMR (500 MHz, acetone-d6) 
δ (ppm): 1.13 (m, 6H); 2.67 (m, 4H); 3.87 (s, 2H); 3.88 (s, 
3H); 7.18 (s, 1H); 7.41 (s, 1H); 7.58 (d, J = 8.5 Hz, 2H); 
7.71 (d, J = 15.5 Hz, 1H); 7.75 (d, J = 15.5 Hz, 1H); 8.13 
(d, J = 8.5 Hz, 2H). 13C-NMR (125 MHz, acetone-d6) δ 
(ppm) 23.96; 25.88; 53.98; 56.15; 61.82; 110.20; 118.46; 
121.72; 122.90; 125.50; 128.99; 129.98; 137.00; 138.96; 




Yellow crystals, yield 70%, m.p. 84-85 °C; GC-MS 
(C21H24ClNO3); [M]
+ 373. 1H-NMR (500 MHz, acetone-d6) 
δ (ppm): 1.63 (m, 6H); 2.54 (m, 4H); 3.75 (s, 2H); 3.87 (s, 
3H); 7.14 (s, 1H); 7.40 (s, 1H); 7.57 (d, J = 8.5 Hz, 2H); 
7.69 (d, J = 15.5 Hz, 1H); 7.73 (d, J = 15.5 Hz, 1H); 8.11 
(d, J = 8.4 Hz, 2H). 13C-NMR (125 MHz, acetone-d6) δ 
(ppm): 25.88; 53.98; 56.14; 61.82; 110.19; 118.45; 121.72; 
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122.00; 125.49; 128.98; 129.98; 137.09; 138.95; 146.26; 
148.49; 151.44; 189.36.
ANTIMALARIAL ACTIVITY
An in vitro antimalarial activity of the prepared compounds 
was evaluated against CQ-sensitive strain (3D7) of 
Plasmodium falciparum according to the procedure by 
Rieckmann et al. (1978) with some modifications (Syahri 
et al. 2017). The prepared compounds were dissolved in 
DMSO and prepared in a series of concentrations (100.00, 
10.00, 1.00, 0.10, and 0.01 μg/mL) in the RPMI-1640 
culture medium. In this work, chloroquine-diphosphate 
was employed as a reference drug. For the assessment of 
antimalarial activity, ± 1% parasitemia and 5% hematocrit 
was dispensed in 96 well plates followed by the addition 
of the tested compounds. The plates were incubated at 
37 °C for 48 h and stained in 20% Giemsa dyes solution. 
The percentage inhibition of P. falciparum growth and the 
parasitemia percentage was calculated from the number 
of infected erythrocytes for every 1000 erythrocytes on 
a Giemsa-stained thin blood smear. The IC50 values were 
determined by Probit log analysis.
MOLECULAR DOCKING
Molecular docking was performed by following the 
standard docking protocol with CDOCKER method from 
Discovery Studio software. Molecular docking was 
carried out toward protein of CQ-sensitive Pf-DHFR-TS 
with PDB ID of IJ3I (resolution of 2.33 Å) and CQ-
resistant Pf-DHFR-TS with PDB ID of IJ3K (resolution of 
2.10 Å) (Yuvaniyama et al. 2003). The interactions were 
observed in a grid map with a grid box size of 28.567944; 
5.858250; and 59.659172 (X, Y, Z) for 1J3I (radius 10 
Å), while 28.855583; 6.126375; and 60.192417 for 
protein 1J3K (radius 8.793 Å). Proteins were prepared 
in Discovery Studio software by removing co-crystal 
ligands from the structure, adding hydrogen atoms, and 
adjusting the ionizable amino acids (residues) at pH 
7.4 (default protonation). The ligands were predisposed 
according to the standard docking protocol in Discovery 
Studio software to build 3-dimensional geometrics and to 
minimize the energy before the docking process.
During the docking process, the receptor was 
rigidly maintained, and the ligands were allowed to flex. 
The ligand-receptor conformations were generated with 
docking tolerance at 0.25 Å. The conformer fitting was 
started with a set of several nonpolar or polar hotspots 
in the receptor was 500. Meanwhile, the ligand-receptor 
conformations obtained from the docking process were 
fixed at 500 within the relative energy threshold of 20. 
Validation of the docking methods was determined based 
on the root mean square deviation (RMSD) value from the 
re-docking process. The RMSD value generated from the 
re-docking results of the co-crystal ligands to 1J3I and 1J3K 
were 0.6578 and 1.0786 Å, respectively.
LIPINSKI’S ‘RULE OF 5’ PREDICTION
Lipinski’s rule of five is an empirical rule of thumb to 
evaluate physicochemical properties and refine drug 
ability for small molecules. ChemDraw Professional 
15.0 software and Sanjeevini web server were utilized to 
calculate and predict the value of logP, hydrogen bond 
donor, and acceptor as well as the molecular weight 
(Jayaram et al. 2012). 
RESULTS AND DISCUSSION
The QSAR equation model was prepared by selecting the 
training set (19 compounds) and test set (6 compounds). 
The QSAR model was generated based on the training 
set, and the test set performed validation of the model. 
Before QSAR analysis, the IC50 value was converted into 
a logarithmic scale to get a better distribution of IC50 
value. The net atomic charge (q) of the aminoalkylated 
chalcone compounds as the electronic descriptor was 
calculated using the AM1 semi-empirical method, 
followed by statistical analysis using the Multiple Linear 
Regression (MLR) backward methods. Principally, the 
backward method will use all parameters that are used 
at the beginning of the analysis, and further analysis will 
eliminate the considered insignificant parameters from the 
model, and the regression is recalculated. The repetitive 
step is needed until a simpler model (with the fewest 
parameters or descriptors) is obtained, but the result must 
significantly meet the statistical requirements. Based on 
the statistical analysis using the MLR backward method, 
the best QSAR model obtained was:
log IC50 = 705.132 (qC7) - 65.573 (qC3) - 24.845 (qC4) - 
4.634 (qC13) - 220.479.           (1)
Equation (1) shows a good correlation between 
descriptors (q) and antimalarial activity (Table 1). The 
r-value (0.940) indicates that the change of the atomic 
charges at C3 (qC3), C4 (qC4), C7 (qC7), and C13 (qC13) 
atoms from the data set influences 94% of the antimalarial 
activity of the chalcone compound. Accuracy of the 
obtained model to predict the antimalarial activity was also 
proved by the Fcalc/Ftable (> 1) and the PRESS (predictive 
residual sum of squares) (<1) value.
Validation of the obtained QSAR model is needed 
to ensure that the model can predict antimalarial activity 
accurately (Table 2). Validation was performed by plotting 
the logIC50 from the experimental against the predicted 
value (Figure 1). The R2 = 0.931 obtained from the plot 
suggests that the QSAR model obtained was able to 
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predict the experimental antimalarial activity (in vitro) by 
93.1%. Meanwhile, validation of the QSAR model using the 
test set compounds showed R2 of 0.962, which means that 
the model can predict the antimalarial activity quite well. 
Thus, some chalcone compounds with better antimalarial 
activity can be proposed based on this QSAR model. In this 
study, three aminoalkylated chalcone compounds (Figure 
2) were proposed for further synthesis and examined 
theirs in vitro antimalarial activity (Table 3). 
TABLE 1. Statistical parameters from the Multiple Linear Regression
Variables r r2 Adjusted r2 SEE Fcalc/Ftable PRESS
qC3, qC4, qC7, 
qC13
0.940 0.883 0.824 0.300 4.40 0.659
TABLE 2. Data set compounds, experimental antimalarial activity (IC50) (Wilhelm et al. 2015), and predicted log IC50 
using QSAR model
Compound IC50 experiment log IC50 experiment log IC50 QSAR prediction
1 11.30 1.053 1.145
2 15.71 1.196 1.168
3 0.83 -0.081 0.009
4 6.54 0.816 0.841
5a 2.81 0.449 0.550
6 4.90 0.690 0.699
7a 3.77 0.576 0.531
8a 5.75 0.760 0.672
9 2.74 0.438 0.663
10 2.52 0.401 -0.210
11 3.10 0.491 0.556
12a 0.17 -0.770 -0.327
13 0.15 -0.824 -0.704
14 0.14 -0.854 -0.773
15 0.10 -1.000 -0.759
16 1.37 0.137 0.150
17 2.42 0.384 0.478
18 2.73 0.436 0.282
19 3.10 0.491 0.230
21 0.19 -0.721 -0.612
24 0.21 -0.678 -0.102
25 0.06 -1.222 -1.002
26 0.01 -2.000 -1.879
27a 0.07 -1.155 -1.009
28a 0.09 -1.046 -1.001
a) Test set data
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Three aminoalkylated chalcone compounds (4a-4c) 
were obtained in good yield by reacting acetophenone 
derivatives with vanillin via Claisen-Schmidt reaction, 
followed by the Mannich reaction using formaldehyde 
and corresponding secondary amines (morpholine, 
piperidine, and diethylamine) (Figure 2). The synthesized 
compounds were characterized by 1H‒NMR, 13C‒ NMR, and 
GCMS, respectively. 
The 1H‒NMR spectra of the aminoalkylated 
chalcone compounds (4a-4c) shows the characteristic 
signals of the resonances of the alkene group with trans 
conformation at 7.75 and 7.71 ppm (Hα and Hβ) with 
coupling constant of 15.5 Hz. Moreover, there is a singlet 
peak of an alkyl group (3.7 ppm, 2H) that connects the 
aromatic ring with the secondary amines. The presence 
of the downfield signal below 3 ppm signifies the 
methylene proton and alkyl groups of the secondary amines 
  
 


















































FIGURE 1. The plot of experimental log IC50 (in vitro) against predicted log IC50 from the 
training set (a) and test set (b) using QSAR model








(morpholine, piperidine, diethylamine), confirming the 
success of Mannich reaction on the chalcone derivatives. 
The 13C‒NMR spectrum of compound 4b contains a 
chemical shift of carbon atoms from the carbonyl group 
(189.4 ppm), CH3O (56.2 ppm), and CH group (61.5 ppm). 
The α- and β-carbon atoms that attach to the carbonyl group 
give characteristic signals between chemical shift (δ) of 
118.9 - 129.9 ppm and 136.9 - 148.5 ppm, respectively. 
In vitro antimalarial activity of aminoalkylated 
chalcone 4a-4c against 3D7 strain of P. falciparum 
is presented in Table 3. It shows that antimalarial 
activity (IC50) from the predicted and experiments are 
comparable, based on the order of the compound. The 
experimental IC50 of the prepared compounds was higher 
than the predicted calculation. This result was proposed by 
the difference of the strain that has been used in the assay. 
The QSAR model was generated from the data set from the 
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D10 strain, while during the experimental, 3D7 strain was 
used. Both the D10 and 3D7 strain of P. falciparum are 
CQ-sensitive parasite, but it has different gene sequences 
on the genomic DNA (Cui et al. 2012; Triglia et al. 2001). 
Nevertheless, the proposed QSAR equation was capable 
of designing and predicting chalcone-derived compounds 
that have the best antimalarial activity. The in vitro 
antimalarial activity of aminoalkylated chalcone 4a-4c 
was categorized to have an intense activity (Batista et al. 
2009), which proposed by the presence of amine groups 
in chalcone compounds.
TABLE 3. In vitro antimalarial activity of aminoalkylated chalcone, predicted IC50 from QSAR 








QSAR PDB ID 1J3I PDB ID 1J3K
4a 0.62 ± 0.299 0.18 -49.054 -49.674 
4b 0.54 ± 0.649 0.15 -49.230 -52.374 
4c 1.12 ± 0.369 0.23 -48.369 -49.939 
Chloroquine 0.06 ± 0.387 -
Molecular docking analysis was performed to find 
the interaction of the proposed chalcone compound 
against the CQ-sensitive Plasmodium parasite and also 
to investigate the potential activity of the proposed 
compound against the CQ-resistant Plasmodium. Molecular 
docking of the synthesized compound was carried out 
on the CQ-sensitive and CQ-resistance dihydrofolate 
reductases-thymidylate synthase (PfDHFR-TS) protein. 
PfDHFR-TS protein was chosen as the protein target 
because it is involved in the inhibition of the production 
of deoxythymidine monophosphate (dTMP) in the 
thymidylate cycle of Plasmodium parasite. 
Table 3 displays the best CDOCKER docking energy 
for both CQ-sensitive and CQ-resistance proteins by 
chalcone 4b, followed by compounds 4a and 4c. Notably, 
the CDOCKER energy of the proposed compound against 
CQ-resistance protein (1J3K) was lower than the CQ-
sensitive protein (1J3I). It can be seen in Figure 3 that the 
CQ-resistance protein (1J3K) has formed more hydrogen 
bonds (green lines) than the CQ-sensitive protein (1J3I). 
The hydrogen bonds are relatively shorter than phi bonds 
(π, pink line). Thus, hydrogen bonds can build a stronger 
and stable protein-ligand interaction that is resulting in 
lower CDOCKER energy. Thus, the proposed compound 
has the potential to have better in vitro activity against 
CQ-resistant Plasmodium strains.
Interaction of the prepared chalcone compound 
4a-4c to the CQ-sensitive amino acid residue (Figure 3) 
appeared in the form of hydrogen bonds and pi bonds (π) 
with important amino acid residues, such as Ala16, Asp54, 
Cys15, Leu164, Tyr170, and Met55. Those amino acid 
residues are an interdomain interaction of co-crystal ligand 
WR99210 (Yuvaniyama et al. 2003). Generally, the 
lowest energy and the highest number of hydrogen bonds 
were formed by compound 4b, which means chalcone 
4b has the best antimalarial activity according to the 
molecular docking result. This docking result supported 
the outcome of the in vitro antimalarial activity (Table 3). 
The compound 4b has displayed some interactions with 
the amino acid residues of Cys15, Asp54, Phe58, Pro113, 
Ile164, and Ser108 from the CQ-resistant protein (1J3K). 
It has been reported that those amino acid residues were 
the interdomain interaction formed by the co-crystal ligand 
pyrimethamine (Yuvaniyama et al. 2003). 
Based on the molecular docking result in Table 3 
and Figure 3, it appears that compound 4b has the lowest 
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CDOCKER energy and more hydrogen bonds toward the 
CQ-resistance protein, followed by compounds 4c and 
4a, respectively. The CDOCKER binding energy and the 
number of hydrogen bonds can determine the strength 
of the protein-ligand interaction. The lowest CDOCKER 
energy is more favoured to build the best docking pose 
of the protein-ligand. Based on these results, chalcone 
4b was predicted to have a better antimalarial activity to 
CQ-resistance Plasmodium strains and has the potential 
to be developed as the lead compound for antimalarial 
chemotherapy.
Table 4 indicates that all the compounds successfully 
passed the rule of five (Lipinski et al. 1997), thus, 
suggesting that the compounds hold the potential of 
becoming an orally active drug. The increasing number 
of hydrogen bonds may reduce partitioning from 
the aqueous phase into the lipid bilayer membrane 
for permeation by passive diffusion. Furthermore, the 
compound’s molecular mass appeared to be less than 500 
Daltons. An increase in molecular weight may reduce the 
compound concentration at the surface of the intestinal 
epithelium, hence lessens the absorption. An octanol-
water partition coefficient logP of the tested compounds 
also lesser than five, hence preventing poor absorption or 
permeation (Kalita et al. 2019). 











4a 3.78 1 5 387.5
4b 4.93 1 4 385.5
4c 4.79 1 4 373.5
chloroquine 4.81 1 3 319.5
FIGURE 3. 2D and 3D docking pose showing interaction for compound 4b in the binding site 
of a) wild type Pf-DHFR-TS (PDB ID: 1J3I) and b) mutant type Pf-DHFR-TS (PDB ID: 1J3K). 
The colouring atom for the compound is in order as follows: carbons in black, oxygen in red, 
and hydrogen in white. The green line indicates hydrogen-bonding interaction and the pink 
line indicates phi-bonding interaction with distance ascribed in angstroms (Å)
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CONCLUSION
In summary, we have reported the design, synthesis, 
and antimalarial activity evaluation of aminoalkylated 
chalcone derivatives. The prediction accuracy is given by 
the developed QSAR model that capable of assessing the 
IC50 values for antimalarial activity in the experimental 
measurement. The in vitro evaluation of these derivatives 
against 3D7 (CQ-sensitive strain) of P. falciparum 
displayed activity in the μM range. All the compounds 
showed good interaction with the binding site of Pf-
DHFR-TS and pose acceptable drug-likeliness behaviour 
favourable for membrane permeability. Cytotoxicity 
studies of these derivatives are currently underway and 
shall be published in due course of time. 
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